Seth Lederman

This inventor holds 32 USPTO granted patents and 25 published patent applications, plus 5 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Treatments. Top assignees: Columbia University, Tonix Pharma Holdings Limited, Follica, Inc.. Active years: 1995-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seth Lederman. Retrieved from https://idiyas.com/inventor/seth-lederman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32 (Patent Applications = 25)

% Patents Active = 84.4

CIPO Patents = 5 (Patent Applications = 20)

EPO Patents = 4 (Patent Applications = 17)

Average Co-Inventor Count = 2.4

ph-index = 9

Forward Citations = 343(Granted Patents)

Location History:

New York, NY (US) (1995 - 2022)
South Dartmouth, MA (US) (2021 - 2024)

Company Filing History:

Tonix Pharma Holdings Limited

Tonix Pharmaceuticals Holding Corp.

patents

5. 1 out of 1

Krele Pharmaceuticals, Inc.

patent

6. 1 out of 339

The City University of New York

patents

7. 1 out of 1

Tonix Pharma Holdings Limited (Bermuda)

patent

8. 1 out of 2

Tonix Pharmaceuticals Inc.

patents

9. 1 out of 9

Vela Pharmaceuticals, Inc.

patents

10. 2 out of 834,659

Other

patents

Years Active: 1995-2025

Loading Chart...

Areas of Expertise:

Cyclobenzaprine

Hair Growth

Autoimmune Diseases

Depression

Anxiety Disorder

Inflammation

Neurodegenerative Conditions

Antibody Therapy

Transplant Rejection

Sleep Disorders

Alcoholism

Poxviruses

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12263323 - Methods for treating baldness and promoting hair growth (2025-04-01),

2. 12156864 - Analogs of cyclobenzaprine and amitryptilene (2024-12-03),

3. 11998516 - Methods and compositions for treating depression using cyclobenzaprine (2024-06-04),

4. 11826321 - Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions (2023-11-28),

5. 11517557 - Analogs of cyclobenzaprine and amitriptyline (2022-12-06),

6. 11345896 - Synthetic chimeric poxviruses (2022-05-31),

7. 11207511 - Methods for treating baldness and promoting hair growth (2021-12-28),

8. 11026898 - Eutectic formulations of cyclobenzaprine hydrochloride (2021-06-08),

9. 10722478 - Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine (2020-07-28),

10. 10357465 - Eutectic formulations of cyclobenzaprine hydrochloride (2019-07-23),

11. 9918948 - Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine (2018-03-20),

12. 9474728 - Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine (2016-10-25),

13. 9403755 - Isometheptene isomer (2016-08-02),

14. 8481599 - Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism (2013-07-09),

15. 8093300 - Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism (2012-01-10),

Title: The Innovative Journey of Seth Lederman

Introduction: Seth Lederman, a pioneering inventor based in New York, NY, has made significant contributions to the field of innovation with his groundbreaking work in various patents.

Latest Patents: Seth Lederman holds several patents in the medical field, including advancements in pharmaceutical compositions and methods for treating various medical conditions.

Career Highlights: Throughout his illustrious career, Seth Lederman has been recognized for his innovative spirit and dedication to improving healthcare. He founded a biopharmaceutical company focused on developing novel treatments for respiratory diseases.

Collaborations: Seth Lederman has collaborated with leading researchers and scientists in the medical field to further his inventions and bring them to market, showcasing his commitment to advancing healthcare through innovation.

Conclusion: Seth Lederman's passion for innovation and his relentless pursuit of groundbreaking solutions have solidified his reputation as a prominent inventor in the medical industry, leaving a lasting impact on the world of patents and inventions.

Profile summary based on public USPTO records.